Lisa Bell is an accomplished regulatory affairs professional with extensive experience in the biopharmaceutical industry. Currently serving as the Global Head of Regulatory Affairs at argenx since March 2024, Lisa has a proven track record in various leadership roles, including as the Regulatory Affairs Strategist and Founder of Time to Approval Consulting, LLC, and as a founding partner at Modular Regulatory Affairs Consulting, LLC. Prior to these positions, Lisa held executive leadership roles at Coherus BioSciences and BioMarin Pharmaceutical Inc., overseeing regulatory affairs and pharmacovigilance efforts. Lisa's career also includes senior positions at Facet Biotech and Genentech, contributing to significant advancements in regulatory strategy and drug safety. Lisa holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, along with a Master's in Biotechnology and a Bachelor's in Biology from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices